Trump summons White House advisers on rising drug prices

Trump's frustration spread to public view after last week's reports. Pharmaceutical companies increased the prices of hundreds of drugs at the beginning of the year. "Drug companies and companies are not meeting their price commitments. The President tweeted Saturday in a tweet

Trump promised to lower the price of drugs in the United States, which far exceeds the same cost in most countries. other developed countries. Administration officials worked to strengthen the message, even as the costs of pharmaceuticals continued to increase.

"The president has been very clear: drug prices need to go down, not increase," Azar told Fox News on Tuesday, describing a series of policies unveiled by the administration, including targeting intermediaries. of the industry and seeking to eliminate incentives at high prices.

"We are making progress in this area now, but the president has been clear: it must stop," added Azar. "The price of drugs must start to go down, not up, and we will work with the Democrats. We will work with the Republicans to make it happen. "

Drug Manufacturers Increased Prices by More Than 250 Drugs by an Average of 6.3% Compared to January 1, According to Health Software Company Rx Savings Solutions Several other companies announced their own increases in the following days – including Purdue Pharma, which raised the prices of the Oxycontin painkiller and Butrans drug treatment by 9.5% on January 2. The price increases In the other elements of the administration plan, pharmaceutical companies are asked to post the prices in the advertisements and to propose radical changes to the budget. Medicare payment method for certain drugs.

Pharmaceutical companies reacted by largely symbolic promises that gave Trump the titles it had. wanted without substantially changing the way they managed their business or had a lasting impact.

Pfizer, the target of a tweet from Trump in July, which caused the ruin of the industry. , will launch on January 15 the 41 price increases he had promised to delay from last year.

Azar – the president's interlocutor on the cost reduction of drugs – strives to maintain Trump by his side despite criticism of the pharmaceutical industry and Republicans fears the secretary's proposals to health would give the government too much control over the private sector.

Some congressional and administration conservatives bristled at some of Azar's ideas, including an effort to change the cost of Medicare for some drugs criticized by skeptics. it's apparent to a price control on the import.

But Trump remains largely blocked by Azar, said sources close to their relationship, motivated by the desire to keep one of his first campaign promises – and the most popular -. ] This article reads: